CV Sciences, Inc. SEC filings CVSI

CV Sciences, Inc. has 431 filings in SEC EDGAR's recent list, going back to Jan 31, 2011. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
424B5 Prospectus supplement Mar 31, 2022 —
424B5 Prospectus supplement Mar 28, 2022 —
424B5 Prospectus supplement Nov 15, 2021 —
424B5 Prospectus supplement Dec 8, 2020 —
S-3 Shelf registration Apr 21, 2020 —
S-1/A Amended registration statement Sep 23, 2015 —
S-1/A Amended registration statement Aug 3, 2015 —
S-1/A Amended registration statement Jul 30, 2015 —
S-1 Registration statement Jul 20, 2015 —
S-8 Employee stock plan registration Oct 6, 2014 —
S-1/A Amended registration statement Jul 26, 2011 —
S-1/A Amended registration statement Jul 21, 2011 —
S-1/A Amended registration statement Jul 12, 2011 —
S-1/A Amended registration statement Jun 20, 2011 —
S-1 Registration statement Mar 31, 2011 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CVSI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1510964
Former names
CannaVEST Corp. (until Jan 4, 2016); Foreclosure Solutions, Inc. (until Nov 30, 2012)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.